CRISPR Ethics and Governance in Developing Nations

Abstract

The advent of CRISPR-Cas9 gene-editing technology has revolutionized the field of genetics, offering unprecedented precision in editing the DNA of living organisms. While this technology holds immense promise for advancing healthcare, agriculture, and environmental protection, it also raises significant ethical, legal, and governance challenges. In developing nations, where the regulatory and ethical frameworks are still evolving, the adoption of CRISPR technology presents unique challenges. This paper explores the ethical implications of CRISPR gene editing in developing nations, focusing on concerns related to equity, safety, accessibility, and governance. The study examines the global regulatory landscape, highlighting the differences in governance frameworks between developed and developing nations. Through case studies of CRISPR applications in agriculture, medicine, and environmental conservation, the paper evaluates the potential benefits and risks of gene editing in developing countries. The paper concludes with policy recommendations for establishing ethical guidelines and governance structures to ensure responsible use of CRISPR technology in these nations.